OVL
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
🇦🇺 ASX
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in OVL
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in OVL
N/A
OVL investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in OVL also invest in...
Want more shares? Try these...
Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. The company is headquartered in Brisbane, Queensland. The company went IPO on 2016-07-19. The firm is commercializing a treatment platform for obstructive sleep apnea (OSA) and snoring. The Company’s O2Vent devices are designed for any patient that is deemed appropriate for oral appliance therapy, but especially beneficial for the many people that suffer with nasal congestion, obstruction and mouth breathing. The Company’s product offerings include Oventus O2Vent Optima, O2Vent Optima, the ExVent and O2Vent Optima Mini. The Oventus O2Vent Optima product range provides relief to people who suffer snoring or mild to moderate OSA, and those who are unable to tolerate continuous positive airway pressure (CPAP) therapy. Its O2Vent Optima is an oral appliance, which features an integrated airway, using its own airway technology to treat the upper airway. The company provides an uninterrupted airflow during sleep, as well as when a patient experiences nasal obstruction.
📊 Share price
